argenx SE
(ARGX - NASDAQ)
990,32 USD
📋 Profilo Aziendale

argenx SE, a biotechnology company established in Amsterdam, the Netherlands, in 2008, is dedicated to developing innovative therapies primarily for autoimmune diseases.

|